Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Concord Medical Services Holdings (CCM) Cash & Equivalents (2016 - 2018)

Concord Medical Services Holdings (CCM) has disclosed Cash & Equivalents for 9 consecutive years, with $119.6 million as the latest value for Q4 2018.

  • For Q4 2018, Cash & Equivalents rose 19.47% year-over-year to $119.6 million; the TTM value through Dec 2018 reached $119.6 million, up 19.47%, while the annual FY2018 figure was $118.8 million, 37.0% up from the prior year.
  • Cash & Equivalents hit $119.6 million in Q4 2018 for Concord Medical Services Holdings, up from $100.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $119.6 million in Q4 2018 and bottomed at $78.0 million in Q4 2014.
  • Average Cash & Equivalents over 5 years is $99.2 million, with a median of $100.1 million recorded in 2017.
  • Year-over-year, Cash & Equivalents rose 27.77% in 2016 and then decreased 9.96% in 2017.
  • Concord Medical Services Holdings' Cash & Equivalents stood at $78.0 million in 2014, then rose by 11.54% to $87.0 million in 2015, then rose by 27.77% to $111.2 million in 2016, then decreased by 9.96% to $100.1 million in 2017, then increased by 19.47% to $119.6 million in 2018.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $119.6 million, $100.1 million, and $111.2 million for Q4 2018, Q4 2017, and Q4 2016 respectively.